EQL Pharma AB(SE:EQL)
kr 24.85-0.55 (-2.17%)
SE:EQL
EQL Pharma AB earnings date
kr 24.85
At close:-0.55 (-2.17%)
EQL Pharma AB (EQL) Q4 2026 Earnings Report
0 Followers
SE:EQL Q4 2026 EPS Results
- Actual EPS
- SEK 0.31
- Consensus EPS
- SEK 0.11
- Beat/Miss
- Beat by +SEK 0.20
- One Year Ago EPS
- SEK 0.45
SE:EQL Q4 2026 Revenue Results
- Actual Revenue
- SEK 120.17M
- Expected Revenue
- SEK 117.60M
- Beat/Miss
- Beat by +SEK 2.57M
- YoY Revenue Growth
- +6.10%
Earnings Announcement Details
- Quarter
- Q4 2026
- Date
- 05/08/2026
- Time
- Before Open
- Conference Call
- Friday, May 8, 2026
SE:EQL Upcoming Earnings
EQL Pharma AB's next earnings date is estimated for February 4, 2027, based on past reporting schedules.
Q4 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
SE:EQL Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 04, 2027 | 2027 (Q3) | 0.13- | 0.33 | ― | ― |
| Nov 05, 2026 | 2027 (Q2) | 0.140.91 | -0.11 | 927.27% (+1.02) | |
| Aug 07, 2026 | 2027 (Q1) | -0.040.11 | 0.34 | -67.65% (-0.23) | |
| May 08, 2026 | 2026 (Q4) | 0.110.31 | 0.45 | -31.11% (-0.14) | |
| Feb 03, 2026 | 2026 (Q3) | 0.280.33 | 0.35 | -5.71% (-0.02) | |
| Nov 05, 2025 | 2026 (Q2) | -0.06-0.11 | 0.33 | -133.33% (-0.44) | |
| Aug 08, 2025 | 2026 (Q1) | 0.340.34 | 0.36 | -5.56% (-0.02) | |
| May 08, 2025 | 2025 (Q4) | 0.480.45 | 0.16 | 177.78% (+0.29) | |
| Feb 05, 2025 | 2025 (Q3) | 0.330.35 | 0.22 | 59.09% (+0.13) | |
| Nov 06, 2024 | 2025 (Q2) | 0.220.33 | 0.16 | 106.25% (+0.17) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
